Latigo Biotherapeutics, Inc.

Nasdaq: LTGODefensive candidate

64 days public · Pharmaceutical Preparations · $16.00 (+8.18%)

Defensive candidate RANKED

/ 100 fit

Confidence100%

Latigo Biotherapeutics, Inc. (LTGO) is a newly-public pharmaceutical preparations company trading at $16 with an intelligence score of 69 and a deterministic strategy-fit score of 47/100 for the Defensive strategy.

Intelligence score

/ 100 core

Suggested alloc

20%

cap · your limits

Days public

EARLY PUBLIC

Last price

$16.00

live quote

1d change

+8.18%

session

Why selectedLIVE

EQUENCY Reasoning Engine

+Institutional support is high, indicated by 4 Schedule 13D/13G disclosures on file with the SEC, contributing to an institutional sub-score of 93.
+Corporate governance and reporting activity are active, with 2 8-K filings and 20 insider forms submitted.
+Short-term price action demonstrated positive momentum with a 1-day move of plus 8.18%.

RisksLIVE